The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ignatyeva V.I.

Russian Medical Academy of Continuing Professional Education;
National Medical Research Center for Therapy and Preventive Medicine

Yezhov M.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Kontsevaya A.V.

National Medical Research Center for Therapy and Preventive Medicine

Paleev F.N.

National Medical Research Center for Cardiology named after academician E.I. Chazov

Derkach E.V.

National Center for Health Technology Assessment

Omelianovsky V.V.

Russian Medical Academy of Continuing Professional Education;
Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Sorokovikov I.V.

Center for Expertise and Quality Control of Medical Care

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
Russian University of Medicine

Socio-economic damage caused by elevated low-density lipoprotein cholesterol levels

Authors:

Ignatyeva V.I., Yezhov M.V., Kontsevaya A.V., Paleev F.N., Derkach E.V., Omelianovsky V.V., Sorokovikov I.V., Drapkina O.M.

More about the authors

Read: 1696 times


To cite this article:

Ignatyeva VI, Yezhov MV, Kontsevaya AV, et al. Socio-economic damage caused by elevated low-density lipoprotein cholesterol levels. Medical Technologies. Assessment and Choice. 2025;47(2):88‑98. (In Russ.)
https://doi.org/10.17116/medtech20254702188

Recommended articles:
Modern possibilities of intravascular imaging in the treatment of coro­nary artery bifu­rcation lesions. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):434-439

References:

  1. Samorodskaya IV, Starinskaya MA, Boytsov SA. Changes of regional mortality rates from cardiovascular diseases and cognitive disorders In Russia over 2019-2021. Rossijskij kardiologicheskij zhurnal. 2023;28(4):5256. (In Russ.). https://doi.org/10.15829/1560-4071-2023-5256
  2. Dymochka MA, Verigina NB, Turchenkova DA, Krasnovskaya ES, Shkurko MA. Primary disability in the adult population of the Russian Federation for the period 2019 — 2021 (information analysis material). Mediko-sotsial’nye problemy invalidnosti. 2022;(2):8-19. (In Russ.).
  3. Alekyan BG, Boytsov SA, Manoshkina EM, Ganyukov VI. Analysis of Russian national indicators of myocardial revascularization in patients with acute coronary syndrome in 2022. E`ndovaskulyarnaya xirurgiya. 2023;10 (3):260-269 (In Russ.).
  4. Mendis S. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective. Progress in Cardiovascular Diseases. 2010;53(1):10-14.  https://doi.org/10.1016/j.pcad.2010.01.001
  5. Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation. 2016;133(8):742-755.  https://doi.org/10.1161/CIRCULATIONAHA.115.008721
  6. Pogosova NV, Boytsov SA. Preventive Cardiology 2024: State of Problem Perspectives of Development. Kardiologiia. 2024;64(1):4-13. (In Russ.). https://doi.org/10.18087/cardio.2024.1.n2636
  7. Pogosova NV, Boytsov SA, Ausheva AK, Sokolova OY, Salbieva AO, Karpova AV, et al. Traditional risk factor control in the Russian cohort of the hospital arm of EUROASPIRE V survey as compared to the whole study population [abstract]. European Heart Journal. 2021;42(Supplement_1):ehab724.2539. https://doi.org/10.1093/eurheartj/ehab724.2539
  8. Ezhov MV, Kukharchuk VV, Sergienko IV, Alieva AS, Antsiferov MB, Ansheles AA, et al. Disorders of lipid metabolism. Clinical Guidelines 2023. Rossijskij kardiologicheskij zhurnal. 2023;28(5):5471. (In Russ.). https://doi.org/10.15829/1560-4071-2023-5471
  9. Mattiuzzi C, Sanchis-Gomar F, Lippi G. Worldwide burden of LDL cholesterol: Implications in cardiovascular disease. Nutrition, Metabolism and Cardiovascular Diseases. 2020;30(2):241-244.  https://doi.org/10.1016/j.numecd.2019.09.008
  10. Drapkina OM, Imaeva AE, Kutsenko VA, Kapustina AV, Balanova YuA, Maksimov SA, et al. Dyslipidemia in the Russian Federation: population data, associations with risk factors. Kardiovaskulyarnaya terapiya i profilaktika. 2023;22(8S):3791. (In Russ.). https://doi.org/10.15829/1728-8800-2023-3791
  11. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459-2472. https://doi.org/10.1093/eurheartj/ehx144
  12. Kontsevaya AV, Balanova Yu, Imaeva AE, Khudyakov MB, Karpov OI, Drapkina OM. Economic burden of hypercholesterolemia in the Russian Federation. Racional`naya farmakoterapiya v kardiologii. 2018;14(3):393-401. (In Russ.). https://doi.org/10.20996/1819-6446-2018-14-3-393-401
  13. Balanova YuA, Kontsevaya AV, Imaeva AE, Karpov OI, Khudyakov MB. Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation. Racional`naya farmakoterapiya v kardiologii. 2018;14(5):716-724. (In Russ.). https://doi.org/10.20996/1819-6446-2018-14-5-716-724
  14. Lash TL, VanderWeele TJ, Haneuse S, Rothman KJ. Modern epidemiology. 4th edition. Philadelphia: Wolters Kluwer; 2021.
  15. GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162-2203. https://doi.org/10.1016/S0140-6736(24)00933-4
  16. Ezzati M, Lopez AD, Rodgers AA, Murray CJL, eds. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004.
  17. Emerging Risk Factors Collaboration; Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412-423.  https://doi.org/10.1001/jama.2009.1063
  18. Metelskaya VA, Shalnova SA, Yarovaya EB, Kutsenko VA, Boytsov SA, Shlyakhto EV, et al. Lipoprotein Profile in Populations from Regions of the Russian Federation: ESSE-RF Study. International Journal of Environmental Research and Public Health. 2022;19(2):931.  https://doi.org/10.3390/ijerph19020931
  19. Meshkov AN, Ershova AI, Deev D, Metelskaya VA, Zhernakova YuV, Rotar OP, Shalnova SA, Boytsov SA. Distribution of lipid profile values in economically active men and women In Russian Federation: results of the ESSE-RF study for the years 2012-2014. Kardiovaskulyarnaya terapiya i profilaktika. 2017;16(4):62-67. (In Russ.). https://doi.org/10.15829/1728-8800-2017-4-62-67
  20. Cholesterol Treatment Trialists’ (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-1681. https://doi.org/10.1016/S0140-6736(10)61350-5
  21. Cholesterol Treatment Trialists’ (CTT) Collaboration, Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385(9976):1397-1405. https://doi.org/10.1016/S0140-6736(14)61368-4
  22. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, et al; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC); Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE); Emerging Risk Factor Collaboration (ERFC); Prospective Studies Collaboration (PSC). The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis. PLoS One. 2013;8(7):e65174. https://doi.org/10.1371/journal.pone.0065174
  23. Trud i zanyatost’ v Rossii. Statisticheskii sbornik. M.: Rosstat; 2023. (In Russ.).
  24. Ignatyeva VI, Voznyuk IA, Shamalov NA, Reznik AV, Vinitskiy AA, Derkach EV. Social and economic burden of stroke In Russian Federation. SS. Korsakov Journal of Neurology and Psychiatry. 2023;123(8-2):5-15. (In Russ.). https://doi.org/10.17116/jnevro20231230825
  25. Domanski MJ, Tian X, Wu CO, Reis J, Dey AK, Gu Y, et al. Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. Journal of the American College of Cardiology. 2020;76(13):1507-1516. https://doi.org/10.1016/j.jacc.2020.07.059
  26. Duncan MS, Vasan RS, Xanthakis V. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations from the Framingham Study Over 35 Years. Journal of the American Heart Association. 2019;8(11):e011433. https://doi.org/10.1161/JAHA.118.011433

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.